Prevalence of passive exposure to vaping and active vaping in pediatric cystic fibrosis patients

By: Supraja Rengan & Dr. Martha Mckinney

The objective of this study is to evaluate the prevalence of exposure to passive vaping and active vaping in the pediatric cystic fibrosis population. Recently, there has been a trend towards e-cigarette use/vaping in the general population. Current Canadian data shows that the prevalence of e-cigarette use is higher in individuals under the age of 25. Vaping associated lung injury is a newly emerging disease entity with rising morbidity and mortality in the general pediatric population. It is known that passive exposure to smoking results in increased hospitalizations and lower lung function in pediatric cystic fibrosis patients. A previous study in Quebec has shown that there is a high prevalence of passive exposure to cigarette exposure in patients with cystic fibrosis that is greater than the prevalence in the general population. This study aims to assess the prevalence of vaping in caregivers of pediatric cystic fibrosis patients as well as vaping practices of older patients seen in the pediatric cystic fibrosis clinic in Saskatoon. Data will be collected using a self-designed survey to assess smoking and e-cigarette/vaping practices of pediatric patients and their caregivers. Surveys will be distributed as either a paper survey or online survey to individuals attending pediatric cystic fibrosis clinics. Consent will be obtained prior to administering the survey. In the future, we hope that this survey can be expanded to other clinical care settings to assess the prevalence of e-cigarette use and exposure in the pediatric population.
Share this story